Anti-Dihydrofolate reductase (DHFR) antibody [EPR5285]
| Name | Anti-Dihydrofolate reductase (DHFR) antibody [EPR5285] |
|---|---|
| Supplier | Abcam |
| Catalog | ab124814 |
| Prices | $381.00 |
| Sizes | 100 µl |
| Host | Rabbit |
| Clonality | Monoclonal |
| Isotype | IgG |
| Clone | EPR5285 |
| Applications | WB IHC-P ICC/IF |
| Species Reactivities | Mouse, Rat, Human |
| Antigen | Synthetic peptide, corresponding to residues in Human Dihydrofolate reductase (DHFR) |
| Description | Rabbit Monoclonal |
| Gene | DHFR |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
![All lanes : Anti-Dihydrofolate reductase (DHFR) antibody [EPR5285] (ab124814) at 1/10000 dilutionLane 1 : HeLa cell lysatesLane 2 : Jurkat cell lysatesLane 3 : Y-79 cell lysatesLane 4 : 293T cell lysatesLane 5 : Mouse spleen lysatesLane 6 : Rat kidney lysatesLysates/proteins at 10 µg per lane.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_2/8402_Dihydrofolate-reductase-DHFR-Primary-antibodies-ab124814-2.jpg)
All lanes : Anti-Dihydrofolate reductase (DHFR) antibody [EPR5285] (ab124814) at 1/10000 dilutionLane 1 : HeLa cell lysatesLane 2 : Jurkat cell lysatesLane 3 : Y-79 cell lysatesLane 4 : 293T cell lysatesLane 5 : Mouse spleen lysatesLane 6 : Rat kidney lysatesLysates/proteins at 10 µg per lane.
ab124814 at 1/100 dilution, staining Dihydrofolate reductase (DHFR) in paraffin-embedded Human cervical carcinoma tissue by Immunohistochemistry.
Product References
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in - Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in
Allen MD, Luong P, Hudson C, Leyton J, Delage B, Ghazaly E, Cutts R, Yuan M, Syed N, Lo Nigro C, Lattanzio L, Chmielewska-Kassassir M, Tomlinson I, Roylance R, Whitaker HC, Warren AY, Neal D, Frezza C, Beltran L, Jones LJ, Chelala C, Wu BW, Bomalaski JS, Jackson RC, Lu YJ, Crook T, Lemoine NR, Mather S, Foster J, Sosabowski J, Avril N, Li CF, Szlosarek PW. Cancer Res. 2014 Feb 1;74(3):896-907.
The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer - The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer
Garon EB, Finn RS, Hamidi H, Dering J, Pitts S, Kamranpour N, Desai AJ, Hosmer W, Ide S, Avsar E, Jensen MR, Quadt C, Liu M, Dubinett SM, Slamon DJ. Mol Cancer Ther. 2013 Jun;12(6):890-900.